Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.006 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |